BERLIN (Reuters) - BioNTech will offer its coronavirus vaccine to all its employees, it said on Monday, sidestepping Germany's official inoculation programme in what it said was a bid to protect its supply chain from COVID-19 outbreaks.
The German company, which developed the vaccine with U.S. drugmaker Pfizer, said in a statement it would also offer the shot to its suppliers and distributors in Austria.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!